DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Carbimazole is an investigational drug.
There have been 3 clinical trials for Carbimazole. The most recent clinical trial was a Phase 3 trial, which was initiated on May 11th 2017.
The most common disease conditions in clinical trials are Hyperthyroidism, Graves Disease, and Thyrotoxicosis. The leading clinical trial sponsors are Clinical Research Centre, Malaysia, Ministry of Health, Malaysia, and Newcastle-upon-Tyne Hospitals NHS Trust.
Recent Clinical Trials for Carbimazole
|Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism||Ministry of Health, Malaysia||Phase 3|
|Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism||Clinical Research Centre, Malaysia||Phase 3|
|Antithyroid Drug Treatment of Thyrotoxicosis in Young People||Newcastle-upon-Tyne Hospitals NHS Trust||Phase 3|